Recent progress in biological activities and synthetic methodologies of pyrroloquinoxalines

Mini-Reviews in Medicinal Chemistry

Volumn 13, Issue 4, 2013, Pages 607-616

  Huang, Aiping ^a   Ma, Chen ^a,b  

^a SHANDONG UNIVERSITY   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

5 HT3 Receptor agonists; Anti HIV agents; Anticancer agents; Antimalarial agents; PARP 1 inhibitors; Pyrroloquinoxalines; Synthetic methodologies

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTINEOPLASTIC AGENT; LEWIS ACID; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; OMEPRAZOLE; PLATINUM; POLYMER; PROTEIN KINASE B; PROTEIN KINASE B INHIBITOR; PYRROLOQUINOXALINE; QUINOXALINE DERIVATIVE; RUTHENIUM; SC144; SEROTONIN 3 ANTAGONIST; SILVER; UNCLASSIFIED DRUG;

ANTIMALARIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIULCER ACTIVITY; BIOLOGICAL ACTIVITY; CATALYSIS; HUMAN; MICROWAVE RADIATION; NONHUMAN; REVIEW; SUBSTITUTION REACTION; SYNTHESIS;

ANTI-HIV AGENTS; ANTIMALARIALS; ANTINEOPLASTIC AGENTS; CATALYSIS; CELL SURVIVAL; HIV-1; HUMANS; METALS; PLASMODIUM FALCIPARUM; POLY(ADP-RIBOSE) POLYMERASES; PROTO-ONCOGENE PROTEINS C-AKT; PYRROLES; QUINOXALINES;

EID: 84875352786     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: 10.2174/1389557511313040012     Document Type: Review

References (54)

1. Miyashiro, J.; Woods, K. W.; Park, C. H.; Liu, X.; Shi, Y.; Johnson, E. F.; Bouska, J. J.; Olson, A. M.; Luo, Y.; Fry, E. H.; Giranda, V. L.; Penning, T. D. Synthesis and SAR of novel tricyclic quinoxalinone inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1). Bioorg. Med. Chem. Lett., 2009, 19, 4050-4054.
2. Szabó, G.; Kiss, R.; Páyer-Lengyel, D.; Vukics, K.; Szikra, J.; Baki, A.; Molnár, L.; Fischer, J.; Keseru, G. M. Hit-to-lead optimization of pyrrolo[1,2-a]quinoxalines as novel cannabinoid type 1 receptor antagonists. Bioorg. Med. Chem. Lett., 2009, 19, 3471-3475.
3. Desplat, V.; Geneste, A.; Begorre, M.-A.; Fabre, S. B.; Brajot, S.; Massip, S.; Thiolat, D.; Mossalayi, D.; Jayyy, C.; Guillon, J. Synthesis of new pyrrolo[1,2-a]quinoxaline derivatives as potential inhibitors of Akt Kinase. J. Enz. Inh. Med. Chem., 2008, 23, 648-658.
4. Grande, F.; Aiello, F.; De Grazia, O.; Brizzi, A.; Garofalo, A.; Neamati, N. Synthesis and antitumor activities of a series of novel quinoxalinhydrazides. Bioorg. Med. Chem., 2007, 15, 288-294.
5. Maga, G.; Gemma, S.; Fattorusso, C.; Locatelli, G. A.; Butini, S.; Persico, M.; Kukreja, G.; Romano, M. P.; Chiasserini, L.; Savini.; Novellino, E.; Nacci, V.; Spadari, S.; Campiani, G. Specific targeting of hepatitis C virus NS3 RNA helicase. Discovery of the potent and selective competitive nucleotide-mimicking inhibitor QU663. Biochemistry, 2005, 44, 9637-9644.
6. Guillon, J.; Reynolds, R. C.; Leger, J.-M.; Guie, M. A.; Massip, S.; Dallemagne, P.; Jarry, C. Synthesis and preliminary in vitro evaluation of antimycobacterial activity of new pyrrolo[l,2-a]quinoxaline-carboxylic acid hydrazide derivatives. J. Enz. Inh. Med. Chem., 2004, 19, 489-495.
7. Guillon, J.; Grellier, P.; Labaied, M.; Sonnet, P.; Leger, J.-M.; Deprez-Poulain, R.; Forfar-Bares, I.; Dallemagne, P.; Lemaitre, N.; Pehourcq, F.; Rochette, J.; Sergheraert, C.; Jarry, C. Synthesis, antimalarial activity, and molecular modeling of new pyrrolo[1,2-a]quinoxalines, bispyrrolo[1,2-a]quinoxalines, bispyrido[3,2-e]pyrrolo[1,2-a]pyrazines, and bispyrrolo[1,2-a]thieno[3,2-e]pyrazines. J. Med. Chem., 2004, 47, 1997-2009.
8. Sum, F.-W.; Dusza, J.; Santos, E. D.; Grosu, G.; Reich, M.; Du, X.; Albright, D.; Chan, P.; Coupet, J.; Ru, X.; Mazandarani, H.; Saunders, T. Structure-activity study of novel tricyclic benzazepine arginine basopressin antagonists. Bioorg. Med. Chem., 2003, 11, 2195-2198.
9. Parihar, H. S.; Kirschbaum, K. S. Electrostatic potential surfaces of 5-HT3R agonists suggest accessory cation-site adjacent to agonist binding domain. Bioorg. Med. Chem. Lett., 2002, 12, 2743-2747.
10. Campiani, G.; Morelli, E.; Gemma, S.; Nacci, V.; Butini, S.; Hamon, M.; Novellino, E.; Greco, G.; Cagnotto, A.; Goegan, M.; Cervo, L.; Valle, F. D.; Fracasso, C.; Caccia, S.; Mennini, T. Pfyrroloquinoxaline derivatives as high-affinity and selective 5-HT3 receptor agonists: synthesis, further structure-activity relationships, and biological studies. J. Med. Chem., 1999, 42, 4362-4379.
11. Katounina, T.; Besret, L.; Dhilly, M.; Petit-Taboue, M.-C.; Barbelivien, A.; Baron, J.-C.; Dauphin, F.; Barre, L. Synthesis and biological investigations of [18F]MR18445, a 5-HT3 receptor partial agonist. Bioorg. Med. Chem., 1998, 6, 789-795.
12. Mamedov, V. A.; Kalinin, A. A. Pyrrolo[1,2-a]quinoxalines based on quinoxalines. Chem. Heterocycl. Comp., 2010, 46, 641-664.
13. Kalinin, A. A.; Mamedov, V. A. Pyrrolo[1,2-a]quinoxalines based on pyrroles. Chem. Heterocycl. Comp., 2010, 46, 1423-1442.
14. Paul, D.; Yao, D. D.; Zhu, P. P.; Minor, L. D.; Garcia, M. M. 5-Hydroxytryptamine3 (5-HT3) receptors mediate spinal 5-HT antinociception: an antisense approach. J. Pharmacol. Exp. Ther., 2001, 298, 674-678.
15. Grant, K. A.; Colombo, G.; Gatto, G. J. Characterization of the ethanol-like discriminative stimulus effects of 5-HT receptor agonists as a function of ethanol training dose. Psychopharmacology, 1997, 133, 133-141.
16. Campiani, G.; Cappelli, A.; Nacci, V.; Anzini, M.; Vomero, S.; Hamon, M.; Cagnotto, A.; Fracasso, C.; Uboldi, C.; Caccia, S.; Consolo, S.; Mennini, T. Novel and highly potent 5-HT3 receptor agonists based on a pyrroloquinoxaline structure. J. Med. Chem., 1997, 40, 3670-3678.
17. Prunier, H.; Rault, S.; Lancelot, J.-C.; Robba, M.; Renard, P.; Delagrange, P.; Pfeiffer, B.; Caignard, D.-H.; Misslin, R.; Guardiola-Lemaitre, B.; Hamon, M. Novel and selective partial agonists of 5-HT3 receptors. 2. Synthesis and biological evaluation of piperazinopyridopyrrolopyrazines, piperazinopyrroloquinoxalines, and piperazinopyridopyrroloquinoxalines. J. Med. Chem., 1997, 40, 1808-1819.
18. Winslow, J. T.; Insel, T.R. Serotonergic modulation of the rat pup ultrasonic isolation call: studies with 5HT1 and 5HT2 subtypeselective agonists and antagonists. Psychopharmacology, 1991, 105, 513-520.
19. Barre'-Sinoussi, F.; Chermann, J. C.; Rey, F.; Nugeyre, M.; Chamaret, S.; Gruest, J.; Dauguet, C.; Axlar-Blin, C.; Vezinet-Brun, F.; Rouzioux, C.; Rozenbaum, W.; Montagner, L. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome. Science, 1983, 220, 868-871.
20. Campiani, G.; Aiello, F.; Fabbrini, M.; Morelli, E.; Ramunno, A.; Armaroli, S.; Nacci, V.; Garofalo, A.; Greco, G.; Novellino, E.; Maga, G.; Spadari, S.; Bergamini, A.; Ventura, L.; Bongiovanni, B.; Capozzi, M.; Bolacchi, F.; Marini, S.; Coletta, M.; Guiso, G.; Caccia, S. Quinoxalinylethylpyridylthioureas (QXPTs) as potent non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors. Further SAR studies and identification of a novel orally bioavailable hydrazine-based antiviral agent. J. Med. Chem., 2001, 44, 305-315.
21. Plasencia, C.; Grande, F.; Grande, T.; Cao, X. F.; Yamada, R.; Sanchez, T.; Aiello, F.; Garofalo, A.; Neamati, N. Discovery of a novel quinoxalinhydrazide with a broad-spectrum anticancer activity. Cancer. Biol. Ther., 2009, 5, 1-8.
22. Jiang, J.-K.; Shen. M.; Thomas, C. J.; Boxer, M. B. Chiral kinase inhibitors. Curr. Top. Med. Chem., 2011, 11, 800-809.
23. Munoz-Gamez, J. A.; Martin-Oliva, D.; Aguilar-Quesada, R.; Canuelo, A.; Nunez, M. I.; Valenzuela, M. T.; Ruiz de Almodovar, J. M.; De Murcia, G.; Oliver, J. A. PARP inhibition sensitizes p53-deficient breast cancer cells to doxorubicin-induced apoptosis. Biochem. J., 2005, 386, 119-125.
24. Ridley, R. G. Medicinal need, scientific opportunity and the drive for antimalarial drugs. Nature, 2002, 415, 686-693.
25. Ursos, L. M. B.; Roepe, P. D. Chloroquine resistance in the malaria parasite, plasmodium falciparum. Med. Res. Rev., 2002, 22, 465-491.
26. Guillon, J.; Moreau, S.; Mouray, E.; Sinou, V.; Forfar, I.; Fabre, S. B.; Desplat, V.; Millet, P.; Parzy, D.; Jarry, C.; Grellier, P. New ferrocenic pyrrolo[1,2-a]quinoxaline derivatives: Synthesis, and in vitro antimalarial activity. Bioorg. Med. Chem., 2008, 16, 9133-9144.
27. Vidaillac, C.; Guillon, J.; Arpin, C.; Forfar-Bares, I.; Ba, B. B.; Grellet, J.; Moreau, S.; Caignard, D.-H.; Jarry, C.; Quentin, C. Synthesis of omeprazole analogs and evaluation of these as potential inhibitors of the multidrug efflux pump NorA of staphylococcus aureus. Antimicrob. Agents. Chemother., 2007, 51, 831-838.
28. Guillom, J.; Dallemagnea, P.; Pfeifferb, B.; Renard, P.; Manechez, D.; Kervrand, A.; Rault, S. Synthesis of new pyrrolo[1,2-a]quinoxalines: potential non-peptide glucagon receptor antagonists. Eur. J. Med. Chem., 1998, 33, 293-308.
29. Guillon, J.; Forfar, I.; Mamani-Matsuda, M.; Desplat, V.; Salie'ge, M.; Thiolat, D.; Massip, S.; Tabourier, A.; Leger, J.-M.; Dufaure, B.; Haumont, G.; Jarry, C.; Djava Mossalayi, D. Synthesis, analytical behaviour and biological evaluation of new 4-substituted pyrrolo[1,2-a]quinoxalines as antileishmanial agents. Bioorg. Med. Chem., 2007, 15, 194-210.
30. Zhou, J.; Zhang, L. D.; Hu, Y. F.; Hu, H. W. Novel 1,3-dipolar cycloaddition of quinoxalinium N-ylide to alkene promoted by MnO2: a new approach to synthesis of pyrrolo[1,2-a]quinoxalines. J. Chem. Research (S), 1999, 552-553.
31. Mishra, A.; Batra, S. Expeditious Synthesis of imidazole-and pyrrolefused benzodiazocines. Eur. J. Org. Chem., 2010, 4832-4840.
32. Verma, A. K.; Jha, R. R.; Sankar, V. K.; Aggarwal, T.; Singh, R. P.; Chandra, R. Lewis acid-catalyzed selective synthesis of diversely substituted indolo-and pyrrolo[1,2-a]quinoxalines and quinoxalinones by modified pictet-spengler reaction. Eur. J. Org. Chem., 2011, 6998-7010.
33. Maiti, B.; Sun, C.-M. Novel approach towards the synthesis of skeletally diverse benzimidazole-pyrrolo[1,2-a]quinoxaline by SNAr/Pictet-Spengler reaction under focused microwave irradiation. New J. Chem., 2011, 35, 1385-1396.
34. Lin, P.-T.; Salunke, D. B.; Chen, L.-H.; Sun, C.-M. Soluble polymer supported divergent synthesis of tetracyclic benzene-fused pyrazino/diazepino indoles: an advanced synthetic approach to bioactive scaffolds. Org. Biomol. Chem., 2011, 9, 2925-2937.
35. Rotas, G.; Kimbaris, A.; Varvounis, G. Synthesis of 5-alkyl(or aryl)pyrrolo[1,2-a]quinoxalin-4(5H)-ones by denitrocyclisation of N-alkyl(or aryl)-1-(2-nitrophenyl)-1H-pyrrole-2-carboxamides. Evidence of a Smiles rearrangement. Tetrahedron, 2004, 60, 10825-10832.
36. Huang, A.; Liu, F.; Zhan, C.; Liu, Y.; Ma, C. One-pot synthesis of pyrrolo[1,2-a]quinoxalines. Org. Biomol. Chem., 2011, 9, 7351-7357.
37. Chicharro, R.; Castro, S. de.; Reino, J. L.; Aran, V. J. Synthesis of tri-and tetracyclic condensed quinoxalin-2-ones fused across the C-3-N-4 bond. Eur. J. Org. Chem., 2003, 2314-2326.
38. Liu, R.; Huang, Z.; Murray, M. G.; Guo, X.; Liu, G. Quinoxalin-2(1H)-one derivatives as inhibitors against Hepatitis C virus. J. Med. Chem., 2011, 54, 5747-5768.
39. Snyder, D. S.; Tradtrantip, L.; Yao, C.; Kurth, M. J.; Verkman, A. S. Potent, metabolically stable benzopyrimido-pyrrolo-oxazinedione (BPO) CFTR inhibitors for polycystic kidney disease. J. Med. Chem., 2011, 54, 5468-5477.
40. Verma, A. K.; Jha, R. R.; Sankar, V. K.; Aggarwal, T.; Singh, R. P.; Chandra, R. Lewis acid-catalyzed selective synthesis of diversely substituted indolo-and pyrrolo[1,2-a]quinoxalines and quinoxalinones by modified Pictet-Spengler reaction. Eur. J. Org. Chem., 2011, 6998-7010.
41. Yi, C. S.; Yun, S. Y. Scope and mechanistic study of the ruthenium-catalyzed ortho-C-H bond activation and cyclization reactions of arylamines with terminal alkynes. J. Am. Chem. Soc., 2005, 127, 17000-17006.
42. Seregin, I. V.; Schammel, A. W.; Gevorgyan, V. Multisubstituted N-fused heterocycles via transition metal-catalyzed cycloisomerization protocols. Tetrahedron, 2008, 64, 6876-6883.
43. Patil, N. T.; Kavthe, R. D.; Raut, V. S.; Reddy, V. V. N. Hydroamination/hydroarylation cascade of terminal alkynes assisted by tethered hydroxyl groups. J. Org. Chem., 2009, 74, 6315-6318.
44. Patil, N. T.; Kavthe, R. D.; Shinde, V. S.; Sridhar, B. Pt(IV)-catalyzed hydroamination triggered cyclization: a strategy to fused pyrrolo[1,2-a]quinoxalines, indolo[1,2-a]quinoxalines, and indolo[3,2-c]quinolines. J. Org. Chem., 2010, 75, 3371-3380.
45. Patil, N. T.; Lakshmi, P. G. V. V.; Singh, V. AuI-catalyzed direct hydroamination/hydroarylation and double hydroamination of terminal alkynes. Eur. J. Org. Chem., 2010, 4719-4731.
46. Patil, N. T.; Mutyala, A. K.; Lakshmi, P. G. V. V.; Raju, P. V. K.; Sridhar, B. Facile assembly of fused isoquinolines by gold(I)-catalyzed coupling-cyclization reactions between oalkynylbenzaldehydes and aromatic amines containing tethered nucleophiles. Eur. J. Org. Chem., 2010, 1999-2007.
47. Liu, G.; Zhou, Y.; Lin, D.; Wang, J.; Zhang, L.; Jiang, H.; Liu, H. Synthesis of pyrrolo[1,2-a]quinoxalines via gold(I)-mediated cascade reactions. ACS Comb. Sci., 2011, 13, 209-213.
48. Rustagi, V.; Aggarwal, T.; Verma, A. K. Highly efficient Ag(I)-catalyzed regioselective tandem synthesis of diversely substituted quinoxalines and benzimidazoles in water. Green Chem., 2011, 13, 1640-1643.
49. Abbiati, G.; Beccalli, E. M.; Broggini, G.; Paladino, G.; Rossi, E. A valuable synthesis of pyrrolo[1,2-a]quinoxalines, indolo[1,2-a]quinoxalines and their aza-znalogues by palladium-catalyzed intramolecular carbon-nitrogen bond formation. Synthesis, 2005, 17, 2881-2886.
50. Wang, L.; Guo, W.; Guo, X.-X.; Xia, X.-D.; Xiao, W.-J. Synthesis of indolo[1,2-a]quinoxalines via a Pd-catalyzed regioselective C-H olefination/cyclization sequence. Org. Lett., 2012, 14, 740-743.
51. Yuan, Q.; Ma, D. A one-pot coupling/hydrolysis/condensation process to pyrrolo[1,2-a]quinoxaline. J. Org. Chem., 2008, 73, 5159-5162.
52. Reeves, J. T.; Fandrick, D. R.; Tan, Z.; Song, J.; Lee, H.; Yee, N. K.; Senanayake, C.H. Copper-catalyzed annulation of 2-formylazoles with o-aminoiodoarenes. J. Org. Chem., 2010, 75, 992-994.
53. Vaillard, V. A.; Rossi, R. A.; Martin, S. E. Synthesis of pyrrole and indole quinoxalinone and oxazinone derivatives by intramolecular copper-catalyzed reactions. Org. Biomol. Chem., 2011, 9, 4927-4935.
54. Ammermann, S.; Hrib, C.; Jones, P. G.; Mont, W.-W. du.; Kowalsky, W.; Johannes, H.-H. Pyrrolo[1,2a]quinoxalines: Novel synthesis via annulation of 2alkylquinoxalines. Org. Lett., 2012, 14, 5090-5093.